Pharming reported positive Phase II results for leniolisib in rare primary immunodeficiencies linked to PI3Kδ signaling.

Alpha Compute signed agreements to acquire a Pennsylvania oil and gas business with 300+ acres and plans to develop a data ...

Beam Global signed a non-binding agreement to acquire a European drone technology company focused on drones and AI software.

Summit Therapeutics announced ESMO 2026 presentation plans for Phase III HARMONi-GI1 data evaluating ivonescimab in biliary ...

Here Group reported RMB596.8 million fiscal 2026 revenue, launched a $20 million share repurchase program and announced leadership changes.

Vicor shares rose after the company increased its Q3 growth forecast following royalty income from Vertical Power Delivery technology licensing.

Kanzhun Limited announced a $230 million annual cash dividend payout to shareholders, including US$0.510 per ADS.

AbbVie received European approval for RINVOQ to treat active polyarticular juvenile idiopathic arthritis in children aged two ...

TC Energy agreed to sell Energía Occidente de México, owner of the Guadalajara-Manzanillo Pipeline, for approximately $560 million.

GRAIL shares surged after FDA reviewers found no major safety or accuracy concerns for the Galleri multi-cancer blood test.

Merck received Japan approval for KEYJECT, a subcutaneous pembrolizumab formulation available across approved KEYTRUDA ...

Alkermes reported phase 1 results showing ALKS 7290 improved ADHD symptom measures in adults and advanced to phase 2 testing.